U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H15NO
Molecular Weight 165.2322
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Ephedrine

SMILES

CN[C@@H](C)[C@H](O)C1=CC=CC=C1

InChI

InChIKey=KWGRBVOPPLSCSI-WPRPVWTQSA-N
InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10-/m0/s1

HIDE SMILES / InChI

Molecular Formula C10H15NO
Molecular Weight 165.2322
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 17:21:02 UTC 2023
Edited
by admin
on Fri Dec 15 17:21:02 UTC 2023
Record UNII
GN83C131XS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Ephedrine
HSDB   MART.   MI   USP   VANDF   WHO-DD  
Common Name English
(R-(R*,S*))-.ALPHA.-(1-(METHYLAMINO)ETHYL)BENZENEMETHANOL [WHO-IP]
Systematic Name English
EPHEDRINE, ANHYDROUS [WHO-IP]
Common Name English
EPHEDRINE [USP MONOGRAPH]
Common Name English
EPHEDRINE [VANDF]
Common Name English
EPHEDRINE [EP MONOGRAPH]
Common Name English
PSEUDOEPHEDRINE HYDROCHLORIDE IMPURITY A [EP IMPURITY]
Common Name English
EPHEDRINE [MI]
Common Name English
NSC-170951
Code English
(1R,2S)-2-METHYLAMINO-1-PHENYLPROPAN-1-OL
Systematic Name English
EPHEDRINUM, ANHYDROUS [WHO-IP LATIN]
Common Name English
NSC-8971
Code English
EPHEDRINE [MART.]
Common Name English
XENADRINE
Common Name English
L-ERYTHRO-2-(METHYLAMINO)-1-PHENYLPROPAN-1-OL
Common Name English
BENZENEMETHANOL, .ALPHA.-(1-(METHYLAMINO)ETHYL)-, (R-(R*,S*))-
Common Name English
L-EPHEDRINE
Common Name English
(-)-EPHEDRINE
Common Name English
EPHEDRINE [HSDB]
Common Name English
Ephedrine [WHO-DD]
Common Name English
EPHEDRINE, ANHYDROUS
EP   WHO-IP  
Common Name English
Classification Tree Code System Code
WHO-ATC S01FB02
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
WHO-ATC R01AA03
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
WHO-VATC QC01CA26
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
WHO-ATC R03CA02
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
NDF-RT N0000175552
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 1.2
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
CFR 21 CFR 119.1
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
WHO-VATC QR01AA03
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
CFR 21 CFR 1315.13
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
WHO-ATC C01CA26
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
WHO-VATC QS01FB02
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
CFR 21 CFR 341.20
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
NCI_THESAURUS C87053
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
NDF-RT N0000175555
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
WHO-VATC QG04BX90
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
NDF-RT N0000192563
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
DEA NO. 8113
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
CFR 21 CFR 341.16
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
WHO-ATC A08AA56
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
CFR 21 CFR 1314.20
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
WHO-VATC QR03CA02
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
WHO-ATC R01AB05
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
WHO-VATC QR01AB05
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
Code System Code Type Description
NSC
170951
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
EVMPD
SUB13683MIG
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
DRUG BANK
DB01364
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
DRUG CENTRAL
1024
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
SMS_ID
100000088883
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
HSDB
3072
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
MESH
D004809
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
ECHA (EC/EINECS)
206-080-5
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
PUBCHEM
9294
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
WIKIPEDIA
EPHEDRINE
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
NSC
8971
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
EVMPD
SUB11936MIG
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
FDA UNII
GN83C131XS
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
NCI_THESAURUS
C472
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
MERCK INDEX
m4933
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY Merck Index
CAS
299-42-3
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
EPHEDRINE
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY Description: Colourless crystals or a white, crystalline powder; odourless or with a slight, aromatic odour.Solubility: Soluble in water; very soluble in ethanol (~750 g/l) TS; freely soluble in ether R.Category: Antiasthmatic drug.Storage: Ephedrine should be kept in a well-closed container, protected from light.Labelling: The designation on the container should state whether the substance is the hemihydrate or is in the anhydrous form.Additional information. Solutions of Ephedrine in chloroform R may become turbid, especially when the substance contains morethan 10 mg of water per g. Even in the absence of light, Ephedrine is gradually degraded on exposure to a humid atmosphere,the decomposition being faster at higher temperatures. Anhydrous Ephedrine melts at about 38?C, whereas Ephedrinehemihydrate melts at about 42?C.
DAILYMED
GN83C131XS
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
RXCUI
3966
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY RxNorm
IUPHAR
556
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
EPA CompTox
DTXSID0022985
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
ChEMBL
CHEMBL211456
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
CHEBI
15407
Created by admin on Fri Dec 15 17:21:03 UTC 2023 , Edited by admin on Fri Dec 15 17:21:03 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
PARENT->PRECURSOR
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
DIASTEREOISOMER -> DIASTEREOISOMER
DIASTEREOISOMER -> DIASTEREOISOMER
DIASTEREOISOMER -> DIASTEREOISOMER
SALT/SOLVATE -> PARENT
SOLVATE->ANHYDROUS
SALT/SOLVATE -> PARENT
PARENT->PRECURSOR
SALT/SOLVATE -> PARENT
Definition. Ephedrine contains not less than 98.5% and not more than 101.0% of C10H15NO, calculated with reference to the anhydrous substance.
SALT/SOLVATE -> PARENT
DIASTEREOISOMER -> DIASTEREOISOMER
PARENT -> CONSTITUENT ALWAYS PRESENT
ASSAY (HPLC)
Related Record Type Details
PARENT -> IMPURITY
Related Record Type Details
ACTIVE MOIETY